Clovis Oncology Inc to Discuss the ARIEL3 Results Call

19/6/2017 8:30

Llamada en conferencia Clovis Oncology Inc

Clovis Oncology Inc Conference call will be held on 19-jun-2017. During the earnings conference call's session Clovis Oncology Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Clovis Oncology Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and other international markets. We generally target our development programs for the treatment of specific subsets of cancer populations and seek to simultaneously develop, with partners, companion diagnostics that direct our product candidates to the patients that are most likely to benefit from their use. We are currently developing three product candidates: ? Rociletinib, an oral epidermal growth factor receptor ("EGFR"), mutant-selective covalent inhibitor that is currently under review with the U.S. and E.U.    
Leer más Llamada en conferencia

Clovis Oncology Inc (CLVS)

5500 Flatiron Parkway, Boulder Colorado 80301, United States